Treatment of autoimmune ovarian disease by co-administration with mouse zona pellucida protein 3 and DNA vaccine through induction of adaptive regulatory T cells

Journal of Gene Medicine

Volumn 10, Issue 7, 2008, Pages 810-820

  Li, Jinyao ^a   Jin, Huali ^a,c   Zhang, Fuchun ^b   Du, Xiaogang ^a,d   Zhao, Gan ^a   Yu, Yang ^a   Wang, Bin ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b XINJIANG UNIVERSITY   (China)

^c UNIVERSITY OF ILLINOIS   (United States)

^d SICHUAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

AOD; Immune suppression; Immunotherapy; mZP3 protein; T regulatory cells

Indexed keywords

BASILIXIMAB; CELL PROTEIN; COMPLEMENTARY DNA; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; ZONA PELLUCIDA PROTEIN 3;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; GENE DELIVERY SYSTEM; GENE INDUCTION; GENE THERAPY; GENE VECTOR; IMMUNOMODULATION; IMMUNOTHERAPY; IN VIVO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; OVARY DISEASE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CELL PROLIFERATION; DNA PRIMERS; EGG PROTEINS; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY; MEMBRANE GLYCOPROTEINS; MICE; OVARIAN DISEASES; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VACCINES, DNA;

MURINAE; MUS;

EID: 48949120117     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1200     Document Type: Article

References (48)

1. Burton KA, Van Ee CC, Purcell KIM, et al. Autosomal translocation associated with premature ovarian failure. J Med Genet 2000; 37: 2E.
2. Wheatcroft N, Weetman AP. Is premature ovarian failure an autoimmune disease? Autoimmunity 1997; 25: 157-165.
3. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107-134.
4. Coulam CB, Kempers RD, Randall RV. Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 1981; 36:238-240.
5. Rhim SH, Millar SE, Robey F, et al. Autoinumme disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. J Clin Invest 1992; 89: 28-35.
6. Lou Y-H, Park K-K, Agersborg S, et al. Retargeting T cell-mediated inflammation: a new perspective on autoantibody action. J Immunol 2000; 164: 5251-5257.
7. Bagavant H, Sharp C, Kurth B, et al. Induction and immunohistology of autoimmune ovarian disease in cynomolgus macaques (Macaca fascicularis). Am J Pathol 2002; 160: 141-149.
8. Paterson M, Koothan PT, Morris KD, et al. Analysis of the contraceptive potential of antibodies against native and deglycosylated porcine ZP3 in vivo and in vitro. Biol Reprod 1992; 46: 523-534.
9. VandeVoort CA, Schwoebel ED, Dunbar BS. Immunization of monkeys with recombinant complimentary deoxyribonucleic acid expressed zona pellucida proteins. Fertil Steril 1995; 64: 838-847.
10. Sakaguchi S. Naturally arising Foxp3-expressing CD25 + CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-352.
11. Shevach EM. CD4 + CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
12. Viglietta V, Baecher-Allan C, Weiner HL, et al. Loss of functional suppression by CD4 + CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
13. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004; 200: 277-285.
14. Kriegel MA, Lohmann T, Gabler C, et al. Defective suppressor function of human CD4 + CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004; 199: 1285-1291.
15. Asano M, Toda M, Sakaguchi N, et al. Autoimmune disease as a consequence of developmental abnormality of aT cell subpopulation. J Exp Med 1996; 184: 387-396.
16. Gleeson PA, Toh BH, Van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 1996; 149: 97-125.
17. Miyake T, Taguchi O, Ikeda H, et al. Acute oocyte loss in experimental autoimmune oophoritis as a possible model of premature ovarian failure. Am J Obstet Gynecol 1988; 158: 186-192.
18. Smith H, Sakamoto Y, Kasai K, et al. Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol 1991; 147: 2928-2933.
19. Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol 2007; 7: 665-677.
20. Suffia IJ, Reckling SK, Piccirillo CA, et al. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 2006; 203: 777-788.
21. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465.
22. Tarbell KV, Yamazaki S, Olson K, et al. CD25 + CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199: 1467-1477.
23. Masteller EL, Warner MR, Tang Q, et al. Expansion of functional endogenous antigen-specific CD4 + CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005; 175: 3053-3059.
24. Tarbell KV, Petit L, Zuo X, et al. Dendritic cell-expanded, islet-specific CD4 + CD25 + CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 2007; 204: 191-201.
25. Samy ET, Parker LA, Sharp CP, et al. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4 + CD25+ regulatory T cells in the regional lymph node. J Exp Med 2005; 202: 771-781.
26. Jin H, Kang Y, Zheng G, et al. Induction of active immune suppression by co-immunization with DNA- and protein-based vaccines. Virology 2005; 337: 183-191.
27. Kang Y, An H, Zheng G, et al. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression. Biochem Biophys Res Commun 2007; 353: 1034-1039.
28. Li J, Jin H, Zhang A, et al. Enhanced contraceptive response by co-immunization of DNA and protein vaccines encoding the mouse zona pellucida 3 with minimal oophoritis in mouse ovary. J Gene Med 2007; 9: 1095-1103.
29. An H, Li Y, Ma Z, et al. Effect of chemical adjuvants on DNA vaccination. Vaccine 2004; 22: 2925-2935.
30. Zhou G, Parthasarathy G, Somasundaram. T, et al. Expression, purification from inclusion bodies, and crystal characterization of a transition state analog complex of arginine kinase: a model for studying phosphagen kinases. Protein Sci 1997; 6: 444-449.
31. Suri-Payer E, Wei K, Tung KSK. The day 3 thymectomy model of organ-specific autoimmunity. Current Protocols in Immunology, Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds). John Wiley & Sons: New York, NY, 2002.
32. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Meth 1994; 171: 131-137.
33. Reiner SL, Zheng S, Corry DB, et al. Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Meth 1993; 165: 37-46.
34. Härtel C, Adam N, Strunk T, et al. Cytokine responses correlate differentially with age in infancy and early childhood. Clin Exp Immunol 2005; 142: 446-453.
35. Carson R, Vignali D. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Meth 1999; 227: 41-52.
36. Wang Y, Kai H, Chang F, et al. A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelytis. Biochem Biophys Res Commun 2007; 353: 857-862.
37. Chabaud M, Durand JM, Buchs N, et al. Human interleukin-17: AT cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999; 42: 963-970.
38. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70.
39. Bachmaier K, Pummerer C, Kozieradzki I, et al. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 1997; 95: 655-661.
40. Spergel JM, Mizoguchi E, Oettgen H, et al. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999; 103: 1103-1111.
41. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
42. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982; 156: 1565-1576.
43. Nielsen J, Holm TL, Claesson MH. CD4 + CD25+ regulatory T cells: II. Origin, disease models and clinical aspects. APMIS 2004; 112: 642-650.
44. Kohm AP, Carpentier PA, Anger HA, et al. Cutting edge: CD4 + CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002; 169: 4712-4716.
45. Zhang X, Koldzic DN, Izikson L, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25 + CD4+ regulatory T cells. Int Immunol 2004; 16: 249-256.
46. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4 + CD25+ regulatory T cells. J Immunol 2003; 170: 3939-3943.
47. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003; 171: 6323-6327.
48. A kbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725-731.